Recent Quarter Total Invested
$158.51 M
Recent Quarter Institutional Ownership Percentage
45.01%
Total Invested of Last Quarter
$50.22 M
Ownership Percentage of Last Quarter
56.27%
Corvus Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 11/14/2024 | 6.94 M | $36.66 M | 0.00% | 10.41% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 5.56 M | $29.37 M | -6.74% | 8.34% |
| SAMLYN CAPITAL, LLC | 11/14/2024 | 4.53 M | $23.92 M | -26.01% | 6.79% |
| ADAMS STREET PARTNERS LLC | 11/14/2024 | 3.28 M | $17.30 M | 0.00% | 4.91% |
| VIVO CAPITAL, LLC | 11/13/2024 | 1.50 M | $7.91 M | 100.00% | 2.24% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 603,877 | $3.19 M | 100.00% | 0.91% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 563,009 | $2.97 M | 22.36% | 0.84% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 500,000 | $2.64 M | 100.00% | 0.75% |
| GHOST TREE CAPITAL, LLC | 11/14/2024 | 500,000 | $2.64 M | 100.00% | 0.75% |
| MORGAN STANLEY | 11/14/2024 | 393,262 | $2.08 M | 5.89% | 0.59% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 386,588 | $2.04 M | -31.45% | 0.58% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 376,121 | $1.99 M | 100.00% | 0.56% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 331,360 | $1.75 M | 100.00% | 0.50% |
| MARSHALL WACE, LLP | 11/14/2024 | 323,211 | $1.71 M | 333.50% | 0.48% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 311,288 | $1.64 M | 52.15% | 0.47% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 218,962 | $1.16 M | 753.65% | 0.33% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 218,300 | $1.15 M | 100.00% | 0.33% |
| STATE STREET CORP | 11/14/2024 | 178,246 | $941,139 | 48.16% | 0.27% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 152,800 | $806,784 | 100.00% | 0.23% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 137,031 | $723,524 | 64.66% | 0.21% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 127,332 | $672,313 | 100.00% | 0.19% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 127,300 | $672,144 | 0.00% | 0.19% |
| TOWERVIEW LLC | 11/06/2024 | 117,500 | $620,400 | -70.63% | 0.18% |
| CITADEL ADVISORS LLC | 11/14/2024 | 97,073 | $512,545 | 83.12% | 0.15% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 79,735 | $420,000 | 100.00% | 0.12% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 71,552 | $377,795 | 49.73% | 0.11% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 63,800 | $336,864 | 100.00% | 0.10% |
| JACKSON SQUARE CAPITAL, LLC | 10/31/2024 | 63,773 | $336,721 | 0.00% | 0.10% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 61,300 | $323,664 | -45.94% | 0.09% |
| CITADEL ADVISORS LLC | 11/14/2024 | 58,900 | $310,992 | 636.25% | 0.09% |
| HIKARI POWER LTD | 10/25/2024 | 49,959 | $264,000 | 0.00% | 0.07% |
| JPMORGAN CHASE & CO | 11/08/2024 | 49,556 | $261,656 | 441.48% | 0.07% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 44,400 | $234,432 | 208.33% | 0.07% |
| MISSION WEALTH MANAGEMENT, LP | 10/31/2024 | 40,000 | $211,200 | 100.00% | 0.06% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 37,600 | $198,528 | 152.35% | 0.06% |
| AVITY INVESTMENT MANAGEMENT INC. | 10/10/2024 | 27,580 | $145,622 | 138.17% | 0.04% |
| WOLVERINE TRADING, LLC | 11/14/2024 | 27,500 | $141,625 | 100.00% | 0.04% |
| CITADEL ADVISORS LLC | 11/14/2024 | 25,800 | $136,224 | 67.53% | 0.04% |
| ANCORA ADVISORS, LLC | 11/14/2024 | 23,285 | $122,946 | 100.00% | 0.03% |
| QUINN OPPORTUNITY PARTNERS LLC | 11/13/2024 | 22,327 | $117,887 | 0.00% | 0.03% |
| COMMERCE BANK | 11/08/2024 | 20,000 | $105,600 | 0.00% | 0.03% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 18,208 | $96,138 | -0.22% | 0.03% |
| OPPENHEIMER & CO INC | 11/05/2024 | 16,947 | $89,480 | 100.00% | 0.03% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 16,734 | $88,355 | 3,033.71% | 0.03% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 15,694 | $83,000 | 100.00% | 0.02% |
| UBS GROUP AG | 11/14/2024 | 15,681 | $82,795 | 20.62% | 0.02% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 15,668 | $82,727 | 0.00% | 0.02% |
| WOLVERINE TRADING, LLC | 11/14/2024 | 14,100 | $72,615 | 100.00% | 0.02% |
| XTX TOPCO LTD | 11/14/2024 | 14,086 | $74,374 | 100.00% | 0.02% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 12,080 | $63,782 | 100.00% | 0.02% |
Corvus Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CRVS shares?
During the previous two years, 79 institutional investors and hedge funds held shares of Corvus Pharmaceuticals, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 6.94 M
Point72 Asset Management, L.P.: 5.56 M
SAMLYN CAPITAL, LLC: 4.53 M
ADAMS STREET PARTNERS LLC: 3.28 M
Vivo Capital, LLC: 1.5 M
BlackRock Funding, Inc. /DE: 603,877
-
What percentage of Corvus Pharmaceuticals, Inc. stock is owned by institutional investors?
45.01% of Corvus Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CRVS ?
Institutional investors have bought a total of 29.61 M shares in the last 24 months. This purchase volume represents approximately $264.98 M in transactions.